EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, McKesson Europe AG's enterprise value is €0 Mil.
McKesson Europe AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 was €140 Mil. Therefore, McKesson Europe AG's EV-to-EBITDA for today is 0.00.
The historical rank and industry rank for McKesson Europe AG's EV-to-EBITDA or its related term are showing as below:
LTS:0OPB's EV-to-EBITDA is not ranked *
in the Medical Distribution industry.
Industry Median: 9.99 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
McKesson Europe AG EV-to-EBITDA Historical Data
The historical data trend for McKesson Europe AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of McKesson Europe AG's EV-to-EBITDA
For the Medical Distribution subindustry, McKesson Europe AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McKesson Europe AG's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where McKesson Europe AG's EV-to-EBITDA falls into.
McKesson Europe AG's current Enterprise Value is €0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. McKesson Europe AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2022 was €140 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
McKesson Europe AG (LTS:0OPB) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
McKesson Europe AG's PE Ratio for today is calculated as:
McKesson Europe AG's share price for today is €24.61722.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. McKesson Europe AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was €-4.290.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of McKesson Europe AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
McKesson Europe AG (LTS:0OPB) Business Description
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0OPB has been successfully added to your 